In the largest genetic study to date on Polycystic ovary syndrome, a leading cause of female infertility, an international team of scientists using data from more than 100,000 women including data from consenting 23andMe customers, found new genetic associations for the condition and further evidence of its associations with metabolic disorders, menopause, and depression.

As part of a collaboration with 23andMe, the personalized medicine company Celmatix is looking to dramatically improve the diagnosis and treatment of infertility. Infertility affects a large portion of the...

New research by scientists at the University of Cambridge and ten other institutions, including 23andMe, has uncovered half a dozen genetic variants associated with polycystic ovary syndrome, the most common...